Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround
(NASDAQ:TRIB), -Trinity Biotech projects it reached Adjusted EBITDA1 -positive operations during Q2 2025 and expects to be Adjusted EBITDA1 positive going forward, reflecting continued strong execution on its comprehensive transformation plan.- – The Company now expects to be meaningfully Adjusted EBITDA1 -positive and cashflow positive from ongoing operating activities, starting Q3 2025 and into the […]